Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMC

[Research progress of tissue engineering technology in promoting revascularization of necrotic femoral bone tissue]

Lin M., Yang J., Yan W., Hu N., Liu Z., Zhang L.

Laboratory Study on Hip, published in Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2021) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2021)
Reported sample size
—
Source database
Europe PMC
PMID
34779177
PMCID
PMC8586766
DOI
10.7507/1002-1892.202105047

Abstract (original English)

Objective To summarize the research progress of tissue engineering technology to promote bone tissue revascularization in osteonecrosis of the femoral head (ONFH). Methods The relevant domestic and foreign literature in recent years was extensively reviewed. The mechanism of femoral head vascularization and the application progress of tissue engineering technology in the promotion of ONFH bone tissue revascularization were summarized. Results Rebuilding or improving the blood supply of the femoral head is the key to the treatment of ONFH. Tissue engineering is a hot spot in current research. It mainly focuses on the three elements of seed cells, scaffold materials, and angiogenic growth factors, combined with three-dimensional printing technology and drug delivery systems to promote the revascularization of the femoral bone tissue. Conclusion The strategy of revascularization of the femoral head can improve the local blood supply and delay or even reverse the progression of ONFH disease.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
FemurFemur HeadHumansFemur Head NecrosisTissue EngineeringPrinting, Three-Dimensional

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research